Dipsite

ADA's 68th Scientific Sessions: A New Look at Insulin Therapy

GNBT is up for acquistion. Most of the big players scratched their research in Oral-lyn except GNBT. Big player will be waiting to see the results from Ph III and will price it some where in between $2 - $3. In such case there will be no dilusion in stock ownership. In current market anything that need finance is downgraded no matter how great the product or business model is.